SONOMA PHARMACEUTICALS INC's ticker is SNOA and the CUSIP is 83558L204. A total of 17 filers reported holding SONOMA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11 | -54.2% | 14,006 | -36.9% | 0.00% | – |
Q2 2023 | $24 | -41.5% | 22,206 | -47.1% | 0.00% | – |
Q1 2023 | $41 | -50.6% | 41,967 | -43.6% | 0.00% | – |
Q4 2022 | $83 | -99.9% | 74,467 | -1.2% | 0.00% | – |
Q3 2022 | $161,000 | -27.1% | 75,367 | -0.5% | 0.00% | – |
Q2 2022 | $221,000 | -8.7% | 75,767 | +25.5% | 0.00% | – |
Q1 2022 | $242,000 | -14.8% | 60,367 | -3.1% | 0.00% | – |
Q4 2021 | $284,000 | -43.9% | 62,267 | -31.3% | 0.00% | -100.0% |
Q3 2021 | $506,000 | -25.3% | 90,667 | -1.6% | 0.00% | 0.0% |
Q2 2021 | $677,000 | -7.8% | 92,167 | -6.7% | 0.00% | 0.0% |
Q1 2021 | $734,000 | +10.2% | 98,826 | +7.7% | 0.00% | 0.0% |
Q4 2020 | $666,000 | -16.0% | 91,734 | -3.2% | 0.00% | 0.0% |
Q3 2020 | $793,000 | +35.3% | 94,734 | +15.2% | 0.00% | 0.0% |
Q2 2020 | $586,000 | +71.8% | 82,234 | +18.0% | 0.00% | – |
Q1 2020 | $341,000 | +33.2% | 69,665 | +18.7% | 0.00% | – |
Q4 2019 | $256,000 | -4.5% | 58,709 | +26.3% | 0.00% | – |
Q3 2019 | $268,000 | -13.5% | 46,474 | +18.9% | 0.00% | – |
Q2 2019 | $310,000 | – | 39,090 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BARD ASSOCIATES INC | 231,505 | $1,680,000 | 0.13% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 15,900 | $115,000 | 0.00% |
Renaissance Technologies | 91,734 | $666,000 | 0.00% |
Gradient Investments LLC | 31 | $0 | 0.00% |
Allworth Financial LP | 65 | $0 | 0.00% |
VANGUARD GROUP INC | 11,369 | $83,000 | 0.00% |
OPTIMUM INVESTMENT ADVISORS | 1 | $0 | 0.00% |
UBS Group AG | 1,114 | $8,000 | 0.00% |
1834 INVESTMENT ADVISORS CO | 13 | $0 | 0.00% |
OSAIC HOLDINGS, INC. | 166 | $1,000 | 0.00% |